Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	antigen binding	IGLV1-40 SPON2 KIR2DL3 IGHV4-4 IGHV3-38-3 IGHV3-74 IGHV3-72 IGHV3-48 IGHV3-43 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-13 IGHV3-7 IGHV3-43D	1.05e-09	190	203	15	GO:0003823
GeneOntologyMolecularFunction	serine-type peptidase activity	TPP2 MBTPS1 RELN PRSS38 ADAM8 PRSS53 PAMR1 HTRA2 LONP2 TMPRSS11E	5.32e-05	207	203	10	GO:0008236
GeneOntologyMolecularFunction	serine hydrolase activity	TPP2 MBTPS1 RELN PRSS38 ADAM8 PRSS53 PAMR1 HTRA2 LONP2 TMPRSS11E	6.50e-05	212	203	10	GO:0017171
GeneOntologyMolecularFunction	histone H4K16 deacetylase activity, NAD-dependent	SIRT1 SIRT2	1.03e-04	2	203	2	GO:0046970
GeneOntologyMolecularFunction	serine-type endopeptidase activity	TPP2 MBTPS1 PRSS38 ADAM8 PRSS53 PAMR1 HTRA2 LONP2 TMPRSS11E	1.46e-04	190	203	9	GO:0004252
GeneOntologyMolecularFunction	ammonium channel activity	SLC12A5 RHCE RHD	2.13e-04	12	203	3	GO:0008519
GeneOntologyMolecularFunction	endopeptidase activity	TPP2 MBTPS1 PRSS38 ADAM20 ERVK-9 ADAM8 PRSS53 PAMR1 ADAMTS3 HTRA2 LONP2 TMPRSS11E ADAMTS13	4.79e-04	430	203	13	GO:0004175
GeneOntologyMolecularFunction	histone H4K deacetylase activity	SIRT1 SIRT2	6.09e-04	4	203	2	GO:0141051
GeneOntologyMolecularFunction	histone H4K16 deacetylase activity, hydrolytic mechanism	SIRT1 SIRT2	6.09e-04	4	203	2	GO:0034739
GeneOntologyBiologicalProcess	immunoglobulin mediated immune response	IL12B IGHV4-4 IGHV3-38-3 IGHV3-74 IGHV3-72 IGHV3-48 IGHV3-43 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-13 IGHV3-7 IGHV3-43D RIF1	9.78e-08	235	204	14	GO:0016064
GeneOntologyBiologicalProcess	B cell mediated immunity	IL12B IGHV4-4 IGHV3-38-3 IGHV3-74 IGHV3-72 IGHV3-48 IGHV3-43 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-13 IGHV3-7 IGHV3-43D RIF1	1.55e-07	244	204	14	GO:0019724
GeneOntologyBiologicalProcess	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	IL12B HLX AGER SCART1 IGHV4-4 IGHV3-38-3 IGHV3-74 IGHV3-72 IGHV3-48 IGHV3-43 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-13 IGHV3-7 IGHV3-43D RIF1 PKN1	8.52e-07	462	204	18	GO:0002460
GeneOntologyBiologicalProcess	leukocyte mediated immunity	IL12B IL13 RASGRP4 SPON2 AGER SCART1 NOS2 IGHV4-4 IGHV3-38-3 IGHV3-74 IGHV3-72 IGHV3-48 IGHV3-43 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-13 IGHV3-7 IGHV3-43D RIF1	1.24e-06	576	204	20	GO:0002443
GeneOntologyBiologicalProcess	lymphocyte mediated immunity	IL12B RASGRP4 AGER SCART1 IGHV4-4 IGHV3-38-3 IGHV3-74 IGHV3-72 IGHV3-48 IGHV3-43 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-13 IGHV3-7 IGHV3-43D RIF1	2.56e-06	449	204	17	GO:0002449
GeneOntologyBiologicalProcess	immune effector process	IL12B IL13 RASGRP4 HLX SPON2 AGER SCART1 NOS2 IGHV4-4 IGHV3-38-3 IGHV3-74 IGHV3-72 IGHV3-48 IGHV3-43 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-13 IGHV3-7 MUC19 IGHV3-43D SIRT1 RIF1 PKN1	4.66e-06	859	204	24	GO:0002252
GeneOntologyBiologicalProcess	adaptive immune response	IL12B HLX IGLV8-61 IGLV1-50 IGLV1-40 AGER SCART1 IGHV4-4 IGHV3-38-3 IGHV3-74 IGHV3-72 IGHV3-48 IGHV3-43 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-13 IGHV3-7 IGHV3-43D SIRT1 RIF1 PKN1	3.09e-05	838	204	22	GO:0002250
GeneOntologyBiologicalProcess	peptidyl-amino acid modification	IL12B IL13 RELN GGNBP2 GALNT2 SRPK2 CHI3L1 RACK1 ZMIZ2 PKD1 MAP3K10 NOS2 NTRK2 DVL2 NOX4 RICTOR SIRT1 SMTNL1 SIRT2 TRIM28 MAP4K1 NEURL1 PKN1 ATM	3.78e-05	976	204	24	GO:0018193
GeneOntologyBiologicalProcess	positive regulation of non-canonical NF-kappaB signal transduction	IL12B NLRP12 TNFSF14 AGER ANK3 TRIM56	7.89e-05	72	204	6	GO:1901224
GeneOntologyBiologicalProcess	peptidyl-serine modification	GGNBP2 GALNT2 SRPK2 RACK1 PKD1 MAP3K10 NTRK2 RICTOR SMTNL1 MAP4K1 PKN1 ATM	8.44e-05	319	204	12	GO:0018209
GeneOntologyCellularComponent	immunoglobulin complex	IGLV8-61 IGLV1-50 IGLV1-40 IGHV4-4 IGHV3-38-3 IGHV3-74 IGHV3-72 IGHV3-48 IGHV3-43 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-13 IGHV3-7 IGHV3-43D	1.11e-10	166	207	15	GO:0019814
Domain	ig	CHL1 KIR2DS2 AGER KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5 NPHS1 SIGLEC1	2.97e-06	190	184	11	PF00047
Domain	Immunoglobulin	CHL1 KIR2DS2 AGER KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5 NPHS1 SIGLEC1	2.97e-06	190	184	11	IPR013151
Domain	WD40_repeat_dom	IFT140 CHAF1B BCAS3 WDR55 RACK1 POC1B WDR35 STXBP5L STXBP5 SPAG9 WDR6 UTP4 ELP2	8.15e-06	297	184	13	IPR017986
Domain	WD40	IFT140 CHAF1B BCAS3 WDR55 RACK1 POC1B WDR35 STXBP5L STXBP5 WDR6 UTP4 ELP2	1.04e-05	259	184	12	PF00400
Domain	WD40	IFT140 CHAF1B BCAS3 WDR55 RACK1 POC1B WDR35 STXBP5L STXBP5 WDR6 UTP4 ELP2	1.46e-05	268	184	12	SM00320
Domain	WD40_repeat	IFT140 CHAF1B BCAS3 WDR55 RACK1 POC1B WDR35 STXBP5L STXBP5 WDR6 UTP4 ELP2	1.69e-05	272	184	12	IPR001680
Domain	WD_REPEATS_1	IFT140 CHAF1B BCAS3 WDR55 RACK1 POC1B WDR35 STXBP5L STXBP5 WDR6 UTP4 ELP2	2.10e-05	278	184	12	PS00678
Domain	WD_REPEATS_2	IFT140 CHAF1B BCAS3 WDR55 RACK1 POC1B WDR35 STXBP5L STXBP5 WDR6 UTP4 ELP2	2.18e-05	279	184	12	PS50082
Domain	WD_REPEATS_REGION	IFT140 CHAF1B BCAS3 WDR55 RACK1 POC1B WDR35 STXBP5L STXBP5 WDR6 UTP4 ELP2	2.18e-05	279	184	12	PS50294
Domain	EGF	RELN TMEM8B ADAM8 GPR179 JAG2 FCGBP SELL PAMR1 CELSR1 CELSR3 SLIT1	2.22e-05	235	184	11	SM00181
Domain	-	IFT140 CHAF1B BCAS3 WDR55 RACK1 POC1B WDR35 STXBP5L STXBP5 SPAG9 WDR6 UTP4 ELP2	2.73e-05	333	184	13	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	IFT140 CHAF1B BCAS3 WDR55 RACK1 POC1B WDR35 STXBP5L STXBP5 SPAG9 WDR6 UTP4 ELP2	2.91e-05	335	184	13	IPR015943
Domain	Lgl_C	STXBP5L STXBP5	9.65e-05	2	184	2	PF08596
Domain	Lgl_C_dom	STXBP5L STXBP5	9.65e-05	2	184	2	IPR013905
Domain	EGF_3	RELN TMEM8B ADAM20 ADAM8 JAG2 SELL PAMR1 CELSR1 CELSR3 SLIT1	1.16e-04	235	184	10	PS50026
Domain	EGF-like_dom	RELN ADAM20 ADAM8 JAG2 FCGBP SELL PAMR1 CELSR1 CELSR3 SLIT1	1.87e-04	249	184	10	IPR000742
Domain	DUF4599	SPATA31A7 SPATA31A3 SPATA31A5	1.94e-04	12	184	3	PF15371
Domain	DUF4599	SPATA31A7 SPATA31A3 SPATA31A5	1.94e-04	12	184	3	IPR027970
Domain	EGF_1	RELN TMEM8B ADAM20 ADAM8 JAG2 SELL PAMR1 CELSR1 CELSR3 SLIT1	2.26e-04	255	184	10	PS00022
Domain	EGF-like_CS	RELN TMEM8B ADAM20 ADAM8 JAG2 SELL PAMR1 CELSR1 CELSR3 SLIT1	2.72e-04	261	184	10	IPR013032
Domain	IG	CHL1 SPEG KIR2DS2 AGER KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5 NPHS1 NTRK2 SIGLEC1	2.86e-04	421	184	13	SM00409
Domain	Ig_sub	CHL1 SPEG KIR2DS2 AGER KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5 NPHS1 NTRK2 SIGLEC1	2.86e-04	421	184	13	IPR003599
Domain	EGF_2	RELN TMEM8B ADAM20 ADAM8 JAG2 SELL PAMR1 CELSR1 CELSR3 SLIT1	3.07e-04	265	184	10	PS01186
Domain	Leu-rich_rpt	LRRC3C NLRP12 RTN4R CIITA PKD1 NTRK2 FBXL16 LRRC25 CD14 SLIT1	3.67e-04	271	184	10	IPR001611
Domain	IG_LIKE	CHL1 IL12B SPEG KIR2DS2 AGER KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5 NPHS1 NTRK2 SIGLEC1	3.75e-04	491	184	14	PS50835
Domain	Ig-like_dom	CHL1 IL12B SPEG KIR2DS2 AGER KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5 NPHS1 NTRK2 SIGLEC1	4.77e-04	503	184	14	IPR007110
Domain	LLGL	STXBP5L STXBP5	5.72e-04	4	184	2	PF08366
Domain	G8_domain	PKHD1 PKHD1L1	5.72e-04	4	184	2	IPR019316
Domain	G8	PKHD1 PKHD1L1	5.72e-04	4	184	2	PS51484
Domain	G8	PKHD1 PKHD1L1	5.72e-04	4	184	2	SM01225
Domain	MAPKKKK	MAP4K5 MAP4K1	5.72e-04	4	184	2	IPR021160
Domain	Lethal2_giant	STXBP5L STXBP5	5.72e-04	4	184	2	IPR000664
Domain	G8	PKHD1 PKHD1L1	5.72e-04	4	184	2	PF10162
Domain	LLGL2	STXBP5L STXBP5	5.72e-04	4	184	2	IPR013577
Domain	DISINTEGRIN_1	ADAM20 ADAM8 ADAMTS3 ADAMTS13	6.32e-04	40	184	4	PS00427
Domain	Reprolysin	ADAM20 ADAM8 ADAMTS3 ADAMTS13	6.32e-04	40	184	4	PF01421
Domain	ADAM_MEPRO	ADAM20 ADAM8 ADAMTS3 ADAMTS13	6.32e-04	40	184	4	PS50215
Domain	DISINTEGRIN_2	ADAM20 ADAM8 ADAMTS3 ADAMTS13	6.32e-04	40	184	4	PS50214
Domain	Peptidase_M12B	ADAM20 ADAM8 ADAMTS3 ADAMTS13	6.32e-04	40	184	4	IPR001590
Domain	Ig-like_fold	CHL1 IL12B SPEG KIR2DS2 AGER PKHD1 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5 NPHS1 FLNB NTRK2 PKHD1L1 SIGLEC1	6.32e-04	706	184	17	IPR013783
Domain	Disintegrin_dom	ADAM20 ADAM8 ADAMTS3 ADAMTS13	6.94e-04	41	184	4	IPR001762
Domain	VWC_out	JAG2 FCGBP MUC19	8.11e-04	19	184	3	SM00215
Domain	-	CHL1 IL12B SPEG KIR2DS2 AGER PKHD1 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 NPHS1 FLNB NTRK2 PKHD1L1 SIGLEC1	8.93e-04	663	184	16	2.60.40.10
Domain	Ammonium_transpt	RHCE RHD	9.47e-04	5	184	2	IPR001905
Domain	Ammonium_transp	RHCE RHD	9.47e-04	5	184	2	PF00909
Domain	NH4_transpt_AmtB-like_dom	RHCE RHD	9.47e-04	5	184	2	IPR024041
Domain	RhesusRHD	RHCE RHD	9.47e-04	5	184	2	IPR002229
Domain	TF_fork_head_CS_2	FOXO4 FOXK1 FOXN1 FOXN4	1.08e-03	46	184	4	IPR030456
Domain	TF_fork_head_CS_1	FOXO4 FOXK1 FOXN1 FOXN4	1.17e-03	47	184	4	IPR018122
Domain	-	LRRC3C NLRP12 RTN4R CIITA PKD1 NTRK2 FBXL16 LRRC25 CD14 SLIT1	1.34e-03	321	184	10	3.80.10.10
Domain	FH	FOXO4 FOXK1 FOXN1 FOXN4	1.37e-03	49	184	4	SM00339
Domain	FORK_HEAD_1	FOXO4 FOXK1 FOXN1 FOXN4	1.37e-03	49	184	4	PS00657
Domain	FORK_HEAD_2	FOXO4 FOXK1 FOXN1 FOXN4	1.37e-03	49	184	4	PS00658
Domain	Fork_head_dom	FOXO4 FOXK1 FOXN1 FOXN4	1.37e-03	49	184	4	IPR001766
Domain	FORK_HEAD_3	FOXO4 FOXK1 FOXN1 FOXN4	1.37e-03	49	184	4	PS50039
Domain	Forkhead	FOXO4 FOXK1 FOXN1 FOXN4	1.37e-03	49	184	4	PF00250
Domain	C4	COL4A3 COL4A6	1.41e-03	6	184	2	SM00111
Domain	Collagen_VI_NC	COL4A3 COL4A6	1.41e-03	6	184	2	IPR001442
Domain	PbH1	PKHD1 PKHD1L1	1.41e-03	6	184	2	SM00710
Domain	NC1_IV	COL4A3 COL4A6	1.41e-03	6	184	2	PS51403
Domain	Haem_d1	STXBP5L STXBP5	1.41e-03	6	184	2	IPR011048
Domain	-	COL4A3 COL4A6	1.41e-03	6	184	2	2.170.240.10
Domain	C4	COL4A3 COL4A6	1.41e-03	6	184	2	PF01413
Domain	FAT	TMTC1 ATM	1.41e-03	6	184	2	PF02259
Domain	PIK-rel_kinase_FAT	TMTC1 ATM	1.41e-03	6	184	2	IPR003151
Domain	PbH1	PKHD1 PKHD1L1	1.41e-03	6	184	2	IPR006626
Domain	EGF	JAG2 SELL PAMR1 CELSR1 CELSR3 SLIT1	1.56e-03	126	184	6	PF00008
Domain	L_dom-like	LRRC3C NLRP12 RTN4R CIITA PKD1 NTRK2 FBXL16 LRRC25 CD14 SLIT1	1.58e-03	328	184	10	IPR032675
Domain	CUB	CSMD2 PAMR1 ADAMTS13 DCBLD2	1.83e-03	53	184	4	PS01180
Domain	GS_dom	ACVRL1 BMPR1B	1.96e-03	7	184	2	IPR003605
Domain	GS	ACVRL1 BMPR1B	1.96e-03	7	184	2	PS51256
Domain	SIR2	SIRT1 SIRT2	1.96e-03	7	184	2	PF02146
Domain	Ssirtuin_cat_dom	SIRT1 SIRT2	1.96e-03	7	184	2	IPR026590
Domain	TGF_beta_GS	ACVRL1 BMPR1B	1.96e-03	7	184	2	PF08515
Domain	Sirtuin	SIRT1 SIRT2	1.96e-03	7	184	2	IPR003000
Domain	SIRTUIN	SIRT1 SIRT2	1.96e-03	7	184	2	PS50305
Domain	GS	ACVRL1 BMPR1B	1.96e-03	7	184	2	SM00467
Domain	-	RHCE RHD	1.96e-03	7	184	2	1.10.3430.10
Domain	Ammonium/urea_transptr	RHCE RHD	1.96e-03	7	184	2	IPR029020
Domain	ADAM_Cys-rich	ADAM20 ADAM8 ADAMTS13	2.31e-03	27	184	3	IPR006586
Domain	ACR	ADAM20 ADAM8 ADAMTS13	2.31e-03	27	184	3	SM00608
Domain	CUB_dom	CSMD2 PAMR1 ADAMTS13 DCBLD2	2.40e-03	57	184	4	IPR000859
Domain	Pectin_lyase_fold/virulence	PKHD1 PKHD1L1	2.60e-03	8	184	2	IPR011050
Domain	PDZ	SHROOM3 LNX2 HTRA2 DVL2 USH1C PDZRN3	2.76e-03	141	184	6	PF00595
Domain	LRRNT	LRRC3C RTN4R PKD1 NTRK2 SLIT1	2.85e-03	98	184	5	IPR000372
Domain	LRRNT	LRRC3C RTN4R PKD1 NTRK2 SLIT1	2.85e-03	98	184	5	SM00013
Domain	Peptidase_S8_His-AS	TPP2 MBTPS1	3.32e-03	9	184	2	IPR022398
Domain	Peptidase_S8_Ser-AS	TPP2 MBTPS1	3.32e-03	9	184	2	IPR023828
Domain	PDZ	SHROOM3 LNX2 HTRA2 DVL2 USH1C PDZRN3	3.50e-03	148	184	6	SM00228
Domain	-	SHROOM3 LNX2 HTRA2 DVL2 USH1C PDZRN3	3.74e-03	150	184	6	2.30.42.10
Domain	LRR	LRRC3C NLRP12 RTN4R CIITA PKD1 CD14 SLIT1	3.84e-03	201	184	7	PS51450
Domain	PDZ	SHROOM3 LNX2 HTRA2 DVL2 USH1C PDZRN3	3.86e-03	151	184	6	PS50106
Domain	PDZ	SHROOM3 LNX2 HTRA2 DVL2 USH1C PDZRN3	3.99e-03	152	184	6	IPR001478
Domain	Peptidase_S8_subtilisin-rel	TPP2 MBTPS1	4.12e-03	10	184	2	IPR015500
Domain	SUBTILASE_ASP	TPP2 MBTPS1	4.12e-03	10	184	2	PS00136
Domain	SUBTILASE_HIS	TPP2 MBTPS1	4.12e-03	10	184	2	PS00137
Domain	SUBTILASE_SER	TPP2 MBTPS1	4.12e-03	10	184	2	PS00138
Domain	CTDL_fold	PKD1 SELL COL4A3 COL4A6 CLEC3B	4.16e-03	107	184	5	IPR016187
Domain	GPS	PKD1 CELSR1 CELSR3	4.50e-03	34	184	3	SM00303
Domain	GPS	PKD1 CELSR1 CELSR3	4.88e-03	35	184	3	PF01825
Pathway	REACTOME_CD22_MEDIATED_BCR_REGULATION	IGHV4-4 IGHV3-74 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-13 IGHV3-7	6.71e-08	35	149	7	MM17219
Pathway	REACTOME_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION	IGHV4-4 IGHV3-74 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-13 IGHV3-7	1.48e-07	39	149	7	MM17212
Pathway	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	KIR2DL1 KIR2DL3 IGHV4-4 IGHV3-74 SELL IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-13 IGHV3-7 SIGLEC1	1.85e-07	135	149	11	MM14781
Pathway	REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION	IGHV4-4 IGHV3-74 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-13 IGHV3-7	4.15e-07	45	149	7	MM14912
Pathway	REACTOME_FCGR_ACTIVATION	IGHV4-4 IGHV3-74 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-13 IGHV3-7	6.55e-07	48	149	7	MM17214
Pathway	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS	IGHV4-4 IGHV3-74 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-13 IGHV3-7	1.31e-06	53	149	7	MM15716
Pathway	REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT	IGHV4-4 IGHV3-74 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-13 IGHV3-7	1.50e-06	54	149	7	MM14655
Pathway	REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS	IGHV4-4 IGHV3-74 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-13 IGHV3-7	1.92e-06	56	149	7	MM14815
Pathway	REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION	IGHV4-4 IGHV3-74 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-13 IGHV3-7	2.45e-06	58	149	7	MM14914
Pathway	REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS	IGHV4-4 IGHV3-74 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-13 IGHV3-7	3.09e-06	60	149	7	MM14872
Pathway	REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION	IGHV4-4 IGHV3-74 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-13 IGHV3-7	3.09e-06	60	149	7	MM14913
Pathway	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	KIR2DS2 IGLV1-40 KIR2DL1 KIR2DL3 KIR2DS1 SELL IGHV3-48 IGHV3-23 IGHV3-13 IGHV3-7 SIGLEC1	5.47e-06	190	149	11	M8240
Pathway	REACTOME_COMPLEMENT_CASCADE	IGHV4-4 IGHV3-74 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-13 IGHV3-7	2.94e-05	84	149	7	MM14653
Pathway	KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	CIITA KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	3.97e-05	88	149	7	M16004
Pathway	REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION	IGHV4-4 IGHV3-74 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-13 IGHV3-7	1.38e-04	107	149	7	MM14915
Pathway	REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS	IGHV4-4 IGHV3-74 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-13 IGHV3-7	2.05e-04	114	149	7	MM14814
Pathway	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL	IGHV4-4 IGHV3-74 SELL IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-13 IGHV3-7	2.73e-04	158	149	8	MM14812
Pathway	REACTOME_CD22_MEDIATED_BCR_REGULATION	IGLV1-40 IGHV3-48 IGHV3-23 IGHV3-13 IGHV3-7	4.56e-04	61	149	5	M27581
Pathway	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	IGHV4-4 IGHV3-74 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-13 IGHV3-7	4.79e-04	131	149	7	MM15717
Pubmed	NullHap--a versatile application to estimate haplotype frequencies from unphased genotypes in the presence of null alleles.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.97e-15	8	208	7	18681957
Pubmed	Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	2.92e-14	10	208	7	12559621
Pubmed	[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	8.00e-14	11	208	7	19664392
Pubmed	Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.91e-13	12	208	7	19936734
Pubmed	Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.91e-13	12	208	7	19181658
Pubmed	Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.91e-13	12	208	7	20371502
Pubmed	KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	4.12e-13	13	208	7	19934297
Pubmed	Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	4.12e-13	13	208	7	19120281
Pubmed	[Study on the polymorphism of killer cell immunoglobulin like receptor (KIR) gene with systemic lupus erythematosus of North population in China].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	4.12e-13	13	208	7	18687225
Pubmed	Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	8.19e-13	14	208	7	19875891
Pubmed	Multiple sclerosis associates with LILRA3 deletion in Spanish patients.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	8.19e-13	14	208	7	19421224
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	8.19e-13	14	208	7	15896204
Pubmed	KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.53e-12	15	208	7	17498266
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.53e-12	15	208	7	20082646
Pubmed	Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.53e-12	15	208	7	19850842
Pubmed	[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.53e-12	15	208	7	20356536
Pubmed	Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.53e-12	15	208	7	19926642
Pubmed	Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.53e-12	15	208	7	20207982
Pubmed	Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.53e-12	15	208	7	19493232
Pubmed	Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.53e-12	15	208	7	20643584
Pubmed	Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.53e-12	15	208	7	19326408
Pubmed	Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	2.70e-12	16	208	7	19897003
Pubmed	Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	2.70e-12	16	208	7	19309280
Pubmed	[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	2.70e-12	16	208	7	16403292
Pubmed	Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	2.70e-12	16	208	7	20652381
Pubmed	No association of KIR genes with Behcet's disease.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	2.70e-12	16	208	7	17868255
Pubmed	Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	2.70e-12	16	208	7	20331834
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	2.70e-12	16	208	7	19000141
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	2.70e-12	16	208	7	20670355
Pubmed	Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	2.70e-12	16	208	7	18668235
Pubmed	Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	2.70e-12	16	208	7	19527230
Pubmed	Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	2.70e-12	16	208	7	19279038
Pubmed	A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	2.70e-12	16	208	7	18643961
Pubmed	HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	2.70e-12	16	208	7	20210919
Pubmed	Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5	3.52e-12	9	208	6	7749980
Pubmed	[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	4.57e-12	17	208	7	19968064
Pubmed	Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	4.57e-12	17	208	7	20878400
Pubmed	Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	4.57e-12	17	208	7	20483367
Pubmed	Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	4.57e-12	17	208	7	19450876
Pubmed	Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	4.57e-12	17	208	7	19761533
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	4.57e-12	17	208	7	20650299
Pubmed	The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	4.57e-12	17	208	7	20173784
Pubmed	The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	4.57e-12	17	208	7	20173792
Pubmed	[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	4.57e-12	17	208	7	19218127
Pubmed	KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	4.57e-12	17	208	7	19169284
Pubmed	Association of killer cell immunoglobulin-like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1	7.29e-12	5	208	5	18755860
Pubmed	Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1	7.29e-12	5	208	5	16112031
Pubmed	Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	7.44e-12	18	208	7	20580654
Pubmed	Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	7.44e-12	18	208	7	20519398
Pubmed	Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	7.44e-12	18	208	7	19846535
Pubmed	Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	7.44e-12	18	208	7	19630074
Pubmed	Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	7.44e-12	18	208	7	20200544
Pubmed	Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	7.44e-12	18	208	7	19046302
Pubmed	Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.17e-11	19	208	7	20600442
Pubmed	KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.17e-11	19	208	7	18571006
Pubmed	Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.17e-11	19	208	7	18778326
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of Paraná.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.17e-11	19	208	7	18848853
Pubmed	Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.79e-11	20	208	7	20193031
Pubmed	Natural killer cells and immune surveillance.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5	1.92e-11	11	208	6	18830515
Pubmed	Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	2.68e-11	21	208	7	19861144
Pubmed	Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis.	IL12B KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	2.93e-11	35	208	8	19683555
Pubmed	[Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].	KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	3.82e-11	12	208	6	20137308
Pubmed	Early onset of somatic mutation in immunoglobulin VH genes during the primary immune response.	IGHV4-4 IGHV3-74 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-13 IGHV3-7	3.91e-11	22	208	7	2499654
Pubmed	Distribution of KIR genes in the population of unrelated individuals homozygous for ancestral haplotype AH8.1 (HLA-A1B8DR3).	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	3.91e-11	22	208	7	20492596
Pubmed	Associations of killer cell immunoglobulin-like receptor genes with complications of rheumatoid arthritis.	KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3	4.35e-11	6	208	5	17882223
Pubmed	[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3	1.23e-10	14	208	6	19489269
Pubmed	Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1	1.52e-10	7	208	5	11169255
Pubmed	1.3 A X-ray structure of an antibody Fv fragment used for induced membrane-protein crystallization.	IGHV3-74 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-13 IGHV3-7	2.04e-10	15	208	6	12657787
Pubmed	Immunogenetic characteristics of patients with autoimmune gastritis.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	3.45e-10	29	208	7	20082482
Pubmed	Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.	KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	4.99e-10	17	208	6	19032228
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5	7.44e-10	18	208	6	20210918
Pubmed	Alternatively spliced forms of human killer inhibitory receptors.	KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5	9.01e-10	9	208	5	8662091
Pubmed	IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes.	IGLV8-61 IGHV4-4 IGHV3-74 IGHV3-72 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-13 IGHV3-7	9.34e-10	77	208	9	15608191
Pubmed	Investigation of activating and inhibitory killer cell immunoglobulin-like receptors and their putative ligands in type 1 diabetes (T1D).	KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1	1.24e-09	4	208	4	26542066
Pubmed	HLA and KIR frequencies in Sicilian Centenarians.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS1 KIR2DS3 KIR2DS5	1.54e-09	20	208	6	20426625
Pubmed	Diversity of the repertoire of p58 killer cell inhibitory receptors in a single individual.	KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1	6.19e-09	5	208	4	10424431
Pubmed	In contrast to other stimulatory natural killer cell immunoglobulin-like receptor loci, several KIR2DS5 alleles predominate in African Americans.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS5	6.19e-09	5	208	4	19410616
Pubmed	Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS1 KIR2DS5	1.40e-08	14	208	5	18945962
Pubmed	The testis-specific VAD1.3/AEP1 interacts with β-actin and syntaxin 1 and directs peri-nuclear/Golgi expression with bipartite nucleus localization (BNL) sequence.	SPATA31A7 SPATA31A3 SPATA31A5 SPATA31A1	1.85e-08	6	208	4	20850414
Pubmed	Targeted disruption of the spermatid-specific gene Spata31 causes male infertility.	SPATA31A7 SPATA31A3 SPATA31A5 SPATA31A1	1.85e-08	6	208	4	25930072
Pubmed	Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS5	4.29e-08	7	208	4	14607943
Pubmed	Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors.	KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS3	4.29e-08	7	208	4	9430220
Pubmed	The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus.	IGHV4-4 IGHV3-74 IGHV3-72 IGHV3-48 IGHV3-43 IGHV3-35 IGHV3-16 IGHV3-7	7.94e-08	91	208	8	9841928
Pubmed	Human diversity in killer cell inhibitory receptor genes.	KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS3	8.54e-08	8	208	4	9430221
Pubmed	Structure and physical map of 64 variable segments in the 3'0.8-megabase region of the human immunoglobulin heavy-chain locus.	IGHV3-48 IGHV3-43 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-7	1.18e-07	39	208	6	8490662
Pubmed	Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals.	KIR2DS2 KIR2DL1 KIR2DS1 KIR2DS3	1.53e-07	9	208	4	18340360
Pubmed	Prognostic role of KIR genes and HLA-C after hematopoietic stem cell transplantation in a patient cohort with acute myeloid leukemia from a consanguineous community.	KIR2DS2 KIR2DL1 KIR2DS1	2.11e-07	3	208	3	29549293
Pubmed	Inhibition of sirtuins 1 and 2 impairs cell survival and migration and modulates the expression of P-glycoprotein and MRP3 in hepatocellular carcinoma cell lines.	ABCC3 SIRT1 SIRT2	2.11e-07	3	208	3	29545174
Pubmed	Associations of killer cell immunoglobulin- like receptor genes with rheumatoid arthritis.	KIR2DS2 KIR2DL2 KIR2DL3	2.11e-07	3	208	3	22960345
Pubmed	[Effect of demethylation treatment on the expression of inhibitory receptor KIR gene in NK-92MI cell line].	KIR2DL1 KIR2DL2 KIR2DL3	2.11e-07	3	208	3	19549382
Pubmed	Homozygosity for killer immunoglobin-like receptor haplotype A predicts complete molecular response to treatment with tyrosine kinase inhibitors in chronic myeloid leukemia patients.	KIR2DS2 KIR2DL2 KIR2DS1	2.11e-07	3	208	3	23380384
Pubmed	Imputation of KIR Types from SNP Variation Data.	KIR2DS2 KIR2DL2 KIR2DL3	2.11e-07	3	208	3	26430804
Pubmed	Cutting edge: selective expression of inhibitory or activating killer cell Ig-like receptors in circulating CD4+ T lymphocytes.	KIR2DS2 KIR2DL2 KIR2DL3	2.11e-07	3	208	3	18292496
Pubmed	Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients.	KIR2DS2 KIR2DL2 KIR2DL3	2.11e-07	3	208	3	30696053
Pubmed	Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation.	KIR2DS1 KIR2DS3 KIR2DS5	2.11e-07	3	208	3	19500138
Pubmed	Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients.	KIR2DS2 KIR2DL2 KIR2DS1	2.11e-07	3	208	3	19877200
Pubmed	Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors.	KIR2DL1 KIR2DL2 KIR2DL3	2.11e-07	3	208	3	15879158
Pubmed	Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus.	KIR2DL2 KIR2DS1 KIR2DS3 KIR2DS5	2.54e-07	10	208	4	21206914
Pubmed	Majority of cerebrospinal fluid-contacting neurons in the spinal cord of C57Bl/6N mice is present in ectopic position unlike in other studied experimental mice strains and mammalian species.	SPATA31A7 SPATA31A3 ADAMTS3 SPATA31A5 SPATA31A1	2.83e-07	24	208	5	32212159
Pubmed	[Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia].	KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS5	5.93e-07	12	208	4	17490516
Interaction	KIR2DS3 interactions	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS5	9.27e-07	20	188	5	int:KIR2DS3
Interaction	KIR3DP1 interactions	KIR2DS2 KIR2DL1 KIR2DS5	3.17e-06	4	188	3	int:KIR3DP1
Interaction	KIR2DL2 interactions	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3	4.91e-06	13	188	4	int:KIR2DL2
Interaction	B4GALT2 interactions	HAUS6 WDR55 ZNF318 USP19 MCM3AP RICTOR MAP7 WDR6	1.60e-05	119	188	8	int:B4GALT2
Interaction	KIR2DS2 interactions	KIR2DS2 KIR2DL2 KIR2DS1 KIR2DS3 KIR2DS5	2.29e-05	37	188	5	int:KIR2DS2
Cytoband	19q13.4	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5 TRIM28	2.96e-09	79	207	8	19q13.4
Cytoband	14q32.33	IGHV4-4 IGHV3-38-3 IGHV3-74 IGHV3-72 IGHV3-48 IGHV3-43 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-13 IGHV3-7	8.68e-09	228	207	11	14q32.33
Cytoband	Ensembl 112 genes in cytogenetic band chr14q32	IFI27L2 JAG2 IGHV4-4 IGHV3-74 IGHV3-72 BEGAIN IGHV3-48 IGHV3-43 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-13 IGHV3-7 TRMT61A	3.53e-07	566	207	14	chr14q32
Cytoband	19q13.1	RASGRP4 TULP2 FCGBP NPHS1	1.14e-04	55	207	4	19q13.1
Cytoband	Ensembl 112 genes in cytogenetic band chr9q12	SPATA31A7 SPATA31A5	5.56e-04	8	207	2	chr9q12
GeneFamily	CD molecules\|Killer cell immunoglobulin like receptors	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	5.72e-11	18	146	7	620
GeneFamily	Immunoglobulin heavy locus at 14q32.33	IGHV4-4 IGHV3-38-3 IGHV3-74 IGHV3-72 IGHV3-48 IGHV3-43 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-13 IGHV3-7 IGHV3-43D	3.88e-08	187	146	12	349
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	TNFSF14 KIR2DS2 ADAM8 BMPR1B KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5 SELL RHCE RHD IGF2R CD14 SIGLEC1 ACKR1	1.26e-07	394	146	16	471
GeneFamily	WD repeat domain containing	IFT140 CHAF1B BCAS3 WDR55 RACK1 POC1B WDR35 STXBP5L STXBP5 WDR6 UTP4 ELP2	1.47e-06	262	146	12	362
GeneFamily	Adhesion G protein-coupled receptors, subfamily C\|CELSR cadherins	CELSR1 CELSR3	1.93e-04	3	146	2	913
GeneFamily	Adhesion G protein-coupled receptors, subfamily C\|CELSR cadherins	CELSR1 CELSR3	1.93e-04	3	146	2	1189
GeneFamily	Forkhead boxes	FOXO4 FOXK1 FOXN1 FOXN4	3.94e-04	43	146	4	508
GeneFamily	Mitogen-activated protein kinase kinase kinase kinases	MAP4K5 MAP4K1	6.37e-04	5	146	2	655
GeneFamily	Elongator acetyltransferase complex	ELP5 ELP2	9.51e-04	6	146	2	539
GeneFamily	Sirtuins	SIRT1 SIRT2	1.32e-03	7	146	2	938
GeneFamily	Type 1 receptor serine/threonine kinases	ACVRL1 BMPR1B	1.32e-03	7	146	2	345
GeneFamily	PDZ domain containing	SHROOM3 LNX2 HTRA2 DVL2 USH1C PDZRN3	1.48e-03	152	146	6	1220
GeneFamily	Proteases, serine	PRSS38 PRSS53 HTRA2 TMPRSS11E	1.68e-03	63	146	4	738
GeneFamily	Glycosyltransferase family 6\|Blood group antigens	RHCE RHD ACKR1	3.28e-03	37	146	3	454
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	AGER NPHS1 SIGLEC1	4.10e-03	40	146	3	592
GeneFamily	Collagens	COL4A3 COL4A6 COL9A3	6.08e-03	46	146	3	490
Coexpression	KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	8.88e-08	49	200	7	M40909
Coexpression	XU_CREBBP_TARGETS_DN	CIITA IGHV3-74 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-13 IGHV3-7	2.29e-07	56	200	7	MM642
Coexpression	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6	IFI27L2 C16orf89 IGHV3-74 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-13 IGHV3-7	1.19e-06	102	200	8	MM872
CoexpressionAtlas	AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000_k-means-cluster#3	IGLV1-40 FCGBP IGHV4-4 IGHV3-74 IGHV3-72 IGHV3-48 NPTX1 IGHV3-23 IGHV3-7 USH1C	4.63e-06	183	184	10	Arv_SC-HD_1000_K3
CoexpressionAtlas	AravindRamakr_StemCell-HD_top-relative-expression-ranked_500_k-means-cluster#2	IGLV1-40 FCGBP IGHV4-4 IGHV3-72 IGHV3-48 IGHV3-23 IGHV3-7 USH1C	1.44e-05	126	184	8	Arv_SC-HD_500_K2
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	IGLV8-61 IGLV1-40 IGHV3-74 IGHV3-72 IGHV3-48 IGHV3-43 COL9A3 IGHV3-23 IGHV3-13 IGHV3-7 PKHD1L1	5.49e-10	177	201	11	c2b0fb5921eea24d248d6e6ccb57c29b0832602c
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	IGLV8-61 IGLV1-40 IGHV3-74 IGHV3-72 IGHV3-48 IGHV3-43 COL9A3 IGHV3-23 IGHV3-13 IGHV3-7 PKHD1L1	5.49e-10	177	201	11	111fb0707ff37ca631d85bb5a09e067ffe568eb8
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGLV8-61 IGLV1-50 IGHV4-4 IGHV3-74 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-16 IGHV3-13 IGHV3-7 STXBP5L	1.62e-09	196	201	11	fec21383435779bf4c632decd3d29c6ca7baebfb
ToppCell	Biopsy_IPF-Immune-Plasma_cells\|Biopsy_IPF / Sample group, Lineage and Cell type	IGLV1-50 IGLV1-40 IGHV4-4 IGHV3-74 IGHV3-72 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-16 IGHV3-7 PKHD1L1	1.62e-09	196	201	11	a1b6a8000b86efcb07843998aa3a49bb1f54bcda
ToppCell	Control-Lymphoid_P\|Control / Disease group, lineage and cell class	IGLV1-50 IGLV1-40 IGHV4-4 IGHV3-74 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-7 PKHD1L1	8.06e-09	176	201	10	d895a6b295cd649273ff80ad7785a3e0ae4c728a
ToppCell	Control-Lymphoid_P-Plasmablast\|Control / Disease group, lineage and cell class	IGLV1-50 IGLV1-40 IGHV4-4 IGHV3-74 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-7 PKHD1L1	8.06e-09	176	201	10	4b4416f342b732d2cc60133838728880326257d8
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGLV1-50 IGLV1-40 IGHV4-4 IGHV3-74 IGHV3-72 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-7	9.47e-09	179	201	10	837ed81f18257f444eaeadc4fac89deedd4e3061
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGLV1-50 IGLV1-40 IGHV4-4 IGHV3-74 IGHV3-72 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-7	9.47e-09	179	201	10	b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	WWC1 ACSS3 COL4A3 SHROOM3 LNX2 ANK3 WWTR1 MAP7 CELSR1 MICAL2	1.76e-08	191	201	10	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	COVID_non-vent-Lymphocytic-Plasma_cell-IgM_Plasmablast\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	IGLV8-61 IGHV4-4 IGHV3-74 IGHV3-72 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-16 IGHV3-13 IGHV3-7	1.94e-08	193	201	10	7b4b0271e4fbece703876acb053ae236afb7cdba
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KCNS2 FOXO4 NPHS1 NPTX1 USH1C FBXL16 CELSR3 SLIT1 NEURL1 HYDIN	2.04e-08	194	201	10	2dcc3b99dbedaf8a6916891c85091ddb79d7ee31
ToppCell	Biopsy_Other_PF-Immune-Plasma_cells\|Biopsy_Other_PF / Sample group, Lineage and Cell type	IGLV1-50 IGHV4-4 IGHV3-72 IGHV3-48 IGHV3-43 IGHV3-35 COL9A3 IGHV3-23 IGHV3-7 PKHD1L1	2.14e-08	195	201	10	d0305c6a68c9e361507b04db94f86873085d49b3
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_cell-B_mature\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGLV1-40 CIITA IGHV3-74 IGHV3-72 SELL COL4A3 IGHV3-48 IGHV3-23 IGHV3-7 MAP4K1	2.36e-08	197	201	10	da175e66d0a743a1b91d46f224b5ff1d37aa5410
ToppCell	10x5'-blood-Lymphocytic_B_plasma\|blood / Manually curated celltypes from each tissue	IGLV1-50 IGLV1-40 IGHV3-74 IGHV3-48 COL9A3 IGHV3-16 IGHV3-13 IGHV3-7 PKHD1L1	2.85e-08	150	201	9	6bab0a8bf78ed7de9e1b67ede7496488f80f4863
ToppCell	droplet-Fat-Gat-18m-Myeloid-monocyte\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RASGRP4 NLRP12 HLX CHI3L1 ADAM8 GK SELL LRRC25 CD14	5.85e-08	163	201	9	3d12a8ca97005308403a3ab136af483ab25f9b0e
ToppCell	3'_v3-blood-Lymphocytic_B_plasma-Plasma_cells\|blood / Manually curated celltypes from each tissue	IGLV1-40 IGHV3-74 COL4A3 IGHV3-48 IGHV3-43 COL9A3 IGHV3-23 IGHV3-7 PKHD1L1	6.50e-08	165	201	9	1c0c24fe252b761cf879b83562e23c02f0b6489f
ToppCell	tumor_Lung-B_lymphocytes-Plasma_cells\|tumor_Lung / Location, Cell class and cell subclass	IGLV8-61 TULP2 IGLV1-50 IGLV1-40 IGHV3-72 IGHV3-23 IGHV3-13 IGHV3-7 PKHD1L1	7.98e-08	169	201	9	b36b7632ce55fc7b6b8b66020563d360b3de6fd7
ToppCell	metastatic_Brain-B_lymphocytes-MALT_B_cells\|metastatic_Brain / Location, Cell class and cell subclass	IGLV8-61 IGLV1-40 IGHV4-4 IGHV3-48 IGHV3-43 COL9A3 IGHV3-23 IGHV3-7 PKHD1L1	1.13e-07	176	201	9	50e207403d48ce1b55a78897adb5519a2430a626
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IGLV1-50 IGLV1-40 IGHV4-4 IGHV3-74 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-7	1.19e-07	177	201	9	4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGLV1-50 IGLV1-40 IGHV4-4 IGHV3-74 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-7	1.19e-07	177	201	9	d746122bf8d208c3aa4d156e8c12d0a0e555c6e5
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGLV1-50 IGLV1-40 IGHV4-4 IGHV3-74 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-7	1.19e-07	177	201	9	fc40918825b7e1eb6861df59dfca944778a64b98
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGLV1-50 IGLV1-40 IGHV4-4 IGHV3-72 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-7	1.30e-07	179	201	9	494febe77c6d4e6a2c6f0928bbf4c84b0301f188
ToppCell	Control-Epithelial_alveolar-AT_1-AT1-AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BMP3 PKHD1 WWC1 COL4A3 COL4A6 SHROOM3 MAP7 CELSR1 CD14	1.50e-07	182	201	9	a95956ce4adccb34cc0c47ebfa1878ce4617904e
ToppCell	10x5'-Liver-Lymphocytic_B_plasma-Plasma_cells\|Liver / Manually curated celltypes from each tissue	IGLV1-50 IGLV1-40 IGHV3-74 IGHV3-72 IGHV3-48 COL9A3 IGHV3-23 IGHV3-7 PKHD1L1	1.65e-07	184	201	9	6f70d8f8ab8362d51f8a58735d42223e06566397
ToppCell	10x5'-Liver-Lymphocytic_B_plasma\|Liver / Manually curated celltypes from each tissue	IGLV1-50 IGLV1-40 IGHV3-74 IGHV3-72 IGHV3-48 COL9A3 IGHV3-23 IGHV3-7 PKHD1L1	1.81e-07	186	201	9	a2c7430781f432c9c90ac4d620f4518ff767a223
ToppCell	LPS-antiTNF-Epithelial_alveolar\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BMP3 AGER WWC1 COL4A3 COL4A6 SHROOM3 ANK3 MAP7 CELSR1	1.89e-07	187	201	9	201ff693e4756ee3e44762885b3a303a77eb535b
ToppCell	healthy_donor-Lymphocytic-Plasma_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	IGLV1-50 IGLV1-40 IGHV4-4 IGHV3-74 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-7	1.98e-07	188	201	9	bd53b0371154cff680226897b61c9809a239d1b6
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGLV8-61 IGHV4-4 IGHV3-72 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-13 IGHV3-7 PCDHGB3	2.70e-07	195	201	9	df009b18898c10686f75cf72b4ec0eff18f5bb50
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGLV1-50 IGHV4-4 IGHV3-72 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-16 IGHV3-7 STXBP5L	2.82e-07	196	201	9	c38e7f533c619afe008de0e99042f7180c2da918
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IGLV8-61 IGHV4-4 IGHV3-74 IGHV3-48 IGHV3-43 COL9A3 IGHV3-23 IGHV3-13 PKHD1L1	2.82e-07	196	201	9	b3d5540fe8ab9a9cbb9ab5350f5cb0e1aae93584
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CHL1 ABCC3 GALNT2 PKHD1 WWC1 COL4A3 ANK3 MAP7 HYDIN	2.94e-07	197	201	9	7e93a97b5ac5ae2f77a4b3141082a1463fed00dd
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_cell-B_naive\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ZNF318 IGLV1-40 CIITA IGHV3-74 SELL IGHV3-48 IGHV3-23 IGHV3-13 IGHV3-7	3.07e-07	198	201	9	79c690d21d3420d0bb1a3b3b4ea2c9aa3810a219
ToppCell	droplet-Limb_Muscle-nan-18m-Myeloid-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLRP12 TNFSF14 CHI3L1 ADAM8 GK SELL LRRC25 CD14	4.22e-07	150	201	8	a003cbaf25a1b5ad4d361dcf162afe0c4b8b78f8
ToppCell	COVID-19_Mild\|World / 5 Neutrophil clusters in COVID-19 patients	RELN RACK1 FOXO4 ANK3 CELSR1 IGF2R GADL1 SIGLEC1	4.67e-07	152	201	8	2ff0980dfd8d430cca14649151d856edef115720
ToppCell	droplet-Heart-nan-18m-Myeloid-cardiac_mast_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RASGRP4 NLRP12 TNFSF14 CHI3L1 ADAM8 SELL CELSR3 CD14	6.26e-07	158	201	8	9596b7b0f6f5157a43d67d2e67fb75a2624a6bb9
ToppCell	droplet-Heart-nan-18m-Myeloid-mast_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RASGRP4 NLRP12 TNFSF14 CHI3L1 ADAM8 SELL CELSR3 CD14	6.26e-07	158	201	8	7ebc8b778c97c0faa79e2d80c98b887fa635f901
ToppCell	droplet-Heart-nan-18m-Myeloid\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RASGRP4 NLRP12 TNFSF14 CHI3L1 ADAM8 SELL CELSR3 CD14	6.26e-07	158	201	8	81a5a73090804d41429d297ba2462a842f39d380
ToppCell	facs-Lung-Endomucin_-18m-Myeloid-Neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RASGRP4 NLRP12 TNFSF14 CHI3L1 ADAM8 ABCA7 SELL CELSR3	7.22e-07	161	201	8	e227f7b711475624cf80e77f235b1783d88d57b4
ToppCell	facs-Lung-Endomucin_-18m-Myeloid-neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RASGRP4 NLRP12 TNFSF14 CHI3L1 ADAM8 ABCA7 SELL CELSR3	7.22e-07	161	201	8	8280a029026c272cae9649b27575831b0dd4e242
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ABCC3 BMPR1B NIBAN1 SHROOM3 ANK3 TMPRSS11E MAP7 CELSR1	7.57e-07	162	201	8	5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81
ToppCell	droplet-Lung-nan-18m-Myeloid-neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RASGRP4 NLRP12 TNFSF14 CHI3L1 ADAM8 GK SELL CD14	8.30e-07	164	201	8	fe9ecdd7a6cbaf910f42654eba75f79bea740a00
ToppCell	droplet-Lung-nan-18m-Myeloid-Neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RASGRP4 NLRP12 TNFSF14 CHI3L1 ADAM8 GK SELL CD14	8.30e-07	164	201	8	0e424a69999eee13d27c4ff4f4ba3df64d3c2bda
ToppCell	droplet-Fat-Gat-18m-Myeloid-myeloid_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RASGRP4 NLRP12 HLX CHI3L1 ADAM8 SELL LRRC25 CD14	8.69e-07	165	201	8	af32eae9324ef053f4f76e2144fb84c6e264c482
ToppCell	droplet-Fat-Gat-18m-Myeloid\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RASGRP4 NLRP12 HLX CHI3L1 ADAM8 SELL LRRC25 CD14	8.69e-07	165	201	8	c3ca2b35299294a5e3d1881fd11617e3ab720692
ToppCell	facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLRP12 CHI3L1 ADAM8 SLC12A5 MAP3K10 AMMECR1 ADAMTS13 SLIT1	9.52e-07	167	201	8	528493896aebe7d03d4b6ad2341b12927859e2e4
ToppCell	facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLRP12 CHI3L1 ADAM8 SLC12A5 MAP3K10 AMMECR1 ADAMTS13 SLIT1	9.52e-07	167	201	8	a82e85caf79395baa48380786d9df32a86dfd1ce
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NLRP12 ATXN7L1 SLC12A5 TMEM174 SPON2 PAMR1 NTRK2 CLEC3B	9.96e-07	168	201	8	d2b91f2adc95dcfa623f8d7ca2df1c6f884da988
ToppCell	-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	IGLV1-40 SPON2 KIR2DL1 SELL FLNB COL9A3 PKHD1L1 MAP4K1	1.09e-06	170	201	8	601630644f09133ee4c5e64499460b55cf3e80a0
ToppCell	10x5'-Lung-Lymphocytic_B-Memory_B_cells\|Lung / Manually curated celltypes from each tissue	CHL1 IGLV8-61 IGHV3-74 COL4A3 IGHV3-48 COL9A3 IGHV3-7 PKHD1L1	1.19e-06	172	201	8	2cb2dc7cfd6db5a98a393b1a84c23abf3d692a53
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-74 NPHS1 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-16 IGHV3-13 IGHV3-7	1.24e-06	173	201	8	7e6bfe85f60834f317941b70d6e0dc3bd527d293
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CHL1 ATP6V1A EYA4 BMPR1B SHROOM3 ADAMTS3 PSD3 NEURL1	1.41e-06	176	201	8	cb21342dd135cc80a50aafe7bf8bf31265db68dd
ToppCell	E18.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RELN CWC25 FCGBP TMTC1 TIMP2 NEURL1 UBASH3B CMTM7	1.47e-06	177	201	8	767b2af5f224d100b22bed32f86cec1cd17e8711
ToppCell	(2)_Plasma_cells\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	IGLV1-50 IGHV4-4 IGHV3-72 IGHV3-48 COL9A3 IGHV3-23 IGHV3-7 PKHD1L1	1.47e-06	177	201	8	ed3c936bb69f9bc7291b4f6cde1d204078117c48
ToppCell	E18.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RELN CWC25 FCGBP TMTC1 TIMP2 NEURL1 UBASH3B CMTM7	1.47e-06	177	201	8	5ef2527e9b41e62f1724cdabaad9d8979266bb7d
ToppCell	E18.5-Endothelial-Endothelial_lymphatic\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RELN CWC25 FCGBP TMTC1 TIMP2 NEURL1 UBASH3B CMTM7	1.47e-06	177	201	8	ae1d2fdd4f67f50c906b27ea084de058c6908aa2
ToppCell	E18.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RELN CWC25 FCGBP TMTC1 TIMP2 NEURL1 UBASH3B CMTM7	1.47e-06	177	201	8	8dfadd9852e0c256363471a7cfe6af120c8c51e0
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGLV1-40 IGHV3-74 SELL IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-13 IGHV3-7	1.54e-06	178	201	8	107dae8b00c4257697a63700e72bb434cdb8406f
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EYA4 BMPR1B COL4A6 SHROOM3 ANK3 ADAMTS3 PSD3 MUC19	1.60e-06	179	201	8	d3438fed0d85d5ed5afa8ff820c45143d77b6c0d
ToppCell	BAL-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGHV4-4 IGHV3-72 IGHV3-43 COL9A3 IGHV3-23 IGHV3-13 IGHV3-7 PKHD1L1	1.67e-06	180	201	8	6a777a308fa3160d31eda468db930e71862020b2
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGLV8-61 IGLV1-50 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-16 IGHV3-13 IGHV3-7	1.74e-06	181	201	8	e47664a264a2c37390d1668ce04eef2e0172f4cb
ToppCell	Control-Epithelial-Basal\|World / Disease state, Lineage and Cell class	EYA4 JAG2 BMPR1B COL4A6 LNX2 ANK3 WWTR1 CELSR1	1.81e-06	182	201	8	759390dde9b18757f7675d13d44c89d0e32f8d93
ToppCell	cellseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IGLV1-40 IGHV4-4 IGHV3-74 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-13 IGHV3-7	1.89e-06	183	201	8	5ab4aa0304b832f98fff89b6c24ad5b7dd014c11
ToppCell	Control-Epithelial_alveolar-AT_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BMP3 WWC1 COL4A6 SHROOM3 ANK3 MAP7 CELSR1 CD14	1.97e-06	184	201	8	51e129b3fcc2df083eda05a3afe3717218b1e52b
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-B_cells-Pre-B\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGLV8-61 BMP3 IGLV1-40 IGHV3-48 IGHV3-23 IGHV3-13 IGHV3-7 CMTM7	2.05e-06	185	201	8	0fa7970709dc957dea95fabbd83263a0335babd5
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BMP3 WWC1 COL4A6 SHROOM3 ANK3 MAP7 CELSR1 CD14	2.05e-06	185	201	8	0d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IGLV1-40 IGHV3-74 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-13 IGHV3-7 PKHD1L1	2.05e-06	185	201	8	79edc1eeb7b5b9123961ac3ecf398ee68d9dddb9
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGLV1-40 IGHV3-74 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-16 IGHV3-13 IGHV3-7	2.05e-06	185	201	8	1704a12153a9b107bf03ecccd1a036cf61334d7a
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IGLV1-40 IGHV3-74 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-13 IGHV3-7 PKHD1L1	2.05e-06	185	201	8	0fff2608f507e019ebb69c27e58fd5be3b049bef
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGLV1-40 IGHV3-74 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-16 IGHV3-13 IGHV3-7	2.05e-06	185	201	8	08bc817908076734d66f2805cb954141f2cc5a18
ToppCell	Control-Epithelial-Club\|World / Disease state, Lineage and Cell class	C16orf89 BMPR1B WWC1 SHROOM3 LNX2 ANK3 WWTR1 MAP7	2.13e-06	186	201	8	9798428691408e17ff2af2fe2d1b345f074d67e4
ToppCell	COPD-Epithelial-Club\|World / Disease state, Lineage and Cell class	C16orf89 BMPR1B WWC1 SHROOM3 LNX2 ANK3 WWTR1 MAP7	2.13e-06	186	201	8	3006f4ab1eaf1eb34c10ca9f7c869603d2d25744
ToppCell	LPS-IL1RA-Epithelial_alveolar\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BMP3 AGER WWC1 COL4A3 COL4A6 SHROOM3 ANK3 MAP7	2.31e-06	188	201	8	6164d467b612767ceba15de34176bcc8e8c36ab8
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	AGER WWC1 COL4A3 COL4A6 SHROOM3 ANK3 MAP7 CELSR1	2.31e-06	188	201	8	43a0508d2524a5b310e89e9422843dcaab999bc3
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	WWC1 COL4A3 SHROOM3 LNX2 ANK3 MAP7 CELSR1 MICAL2	2.31e-06	188	201	8	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGLV1-40 IGHV3-74 IGHV3-72 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-13 IGHV3-7	2.50e-06	190	201	8	79ee6d10dfbb775da149a1104da5823cf63bbb46
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGLV1-40 IGHV3-74 IGHV3-72 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-13 IGHV3-7	2.50e-06	190	201	8	18762ce78ed0b206ade19e1c8ff76a2647489f68
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	RTN4R BMP3 WWC1 NPHS1 COL9A3 ANK3 PKHD1L1 GADL1	2.60e-06	191	201	8	4c4eb61e6179d2f8fc524d2f813db9cba84f67a2
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT2 PKHD1 WWC1 ANK3 SLC16A9 NOX4 USH1C CELSR1	2.60e-06	191	201	8	1c1d13144259b998d4a0e85142f7afef2ef1e63f
ToppCell	IPF-Epithelial-Club\|World / Disease state, Lineage and Cell class	CHL1 C16orf89 BMPR1B WWC1 SHROOM3 ANK3 WWTR1 CELSR1	2.60e-06	191	201	8	3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EYA4 BCAS3 BMPR1B PKHD1 SHROOM3 ANK3 STXBP5 MAP7	2.60e-06	191	201	8	3e828cffa24ded19f591a7ed6c1fe88ad57fdcac
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT2 PKHD1 WWC1 ANK3 SLC16A9 NOX4 USH1C CELSR1	2.60e-06	191	201	8	3c464645d0e7e423f791bd63bf5bcf11f6b590d3
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	WWC1 COL4A3 SHROOM3 LNX2 ANK3 MAP7 CELSR1 MICAL2	2.70e-06	192	201	8	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	WWC1 COL4A3 SHROOM3 LNX2 ANK3 MAP7 CELSR1 MICAL2	2.70e-06	192	201	8	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	NLRP12 IGLV1-40 IGHV4-4 IGHV3-74 IGHV3-43 COL9A3 IGHV3-23 IGHV3-13	2.70e-06	192	201	8	3dddfc93c3c954c4416c7c1f1f161e4d1dcc1233
ToppCell	Epithelial-club_cell\|World / Lineage, Cell type, age group and donor	BMPR1B WWC1 NIBAN1 SHROOM3 ANK3 WWTR1 MAP7 CELSR1	2.81e-06	193	201	8	2bdd09004fa433550958ec42ba4b06271a4aaf7c
ToppCell	wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	RELN ABCA7 FOXO4 LNX2 RICTOR RHCE MICAL2 ACKR1	2.81e-06	193	201	8	be75abfdf5301cf33df8ee9ed92504d44fdf19a6
ToppCell	COVID-19-Lymphoid-Plasma,_B_cells\|COVID-19 / Condition, Lineage and Cell class	IGHV3-74 COL4A3 IGHV3-48 IGHV3-43 COL9A3 IGHV3-23 IGHV3-7 PKHD1L1	2.81e-06	193	201	8	bffd97a73365e1dd23ff3b0320b4860f04ec091a
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGLV8-61 IGHV3-74 IGHV3-72 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-13 IGHV3-7	2.81e-06	193	201	8	282b47dae6043eabb1e13d41d91c07b5ec21cd65
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC3 EYA4 BCAS3 BMPR1B PKHD1 SHROOM3 ANK3 STXBP5	2.92e-06	194	201	8	04bfc555743f7d8821439d05ae442d15e9886c59
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV4-4 IGHV3-74 IGHV3-72 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-16 IGHV3-7	2.92e-06	194	201	8	6ef4aeb8d8e35e4df58ff2a8256caa2113291de9
ToppCell	mild-Myeloid-Neutrophils_1\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	RASGRP4 CHI3L1 ADAM8 GK SELL NIBAN1 IGF2R LRRC25	2.92e-06	194	201	8	ccd911ce3251cd1c60f1fb2ce00650fbe7a379bb
ToppCell	Control-Lymphoid-Plasma,_B_cells\|Control / Condition, Lineage and Cell class	IGLV1-40 SELL COL4A3 IGHV3-48 COL9A3 IGHV3-23 IGHV3-7 PKHD1L1	2.92e-06	194	201	8	31fff4361ebed6308b1e6b2b705ee6e0a695bd0c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC3 PKHD1 WWC1 SHROOM3 ANK3 NOX4 MAP7 CELSR1	2.92e-06	194	201	8	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ABCC3 BMP3 PKHD1 WWC1 NIBAN1 MAP7 CELSR1 SLIT1	2.92e-06	194	201	8	b19e16a76d7342ff9a665d19c9151652916f17d4
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IGLV8-61 IGHV3-74 IGHV3-48 IGHV3-43 IGHV3-35 COL9A3 IGHV3-23 PKHD1L1	3.03e-06	195	201	8	2d18f08f33f3b261c77b8adf87d1a184cc6d7400
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGLV1-50 IGHV4-4 IGHV3-74 IGHV3-72 IGHV3-48 IGHV3-23 IGHV3-16 IGHV3-7	3.03e-06	195	201	8	f3f7f1a77a1edd2b50a8211c76fe289738eb04cf
ToppCell	COVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast\|COVID_vent / Disease condition, Lineage, Cell class and subclass	IGLV1-40 IGHV3-74 IGHV3-72 IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-13 IGHV3-7	3.15e-06	196	201	8	026a06d8d2089806823e6f6453d3ede84ae93bc6
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KCNS2 PCBP4 NPTX1 STXBP5L NTRK2 USH1C CELSR3 SLIT1	3.15e-06	196	201	8	4bdc304c0c9d8bebe1a6a8a27e44acd1e8113725
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_cell\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGLV1-40 CIITA SELL COL4A3 IGHV3-48 IGHV3-23 IGHV3-7 MAP4K1	3.15e-06	196	201	8	e9fe5090452ffdde4bb81b62d57037d823281d00
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22\|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)	BMPR1B IGLV1-40 SPON2 IGHV3-74 IGHV3-48 ANK3 IGHV3-7 RPL12	3.15e-06	196	201	8	939c0d835e9700ac61df60884d3d86053b296410
Disease	schizophrenia (is_implicated_in)	CHL1 RTN4R CHI3L1 AGER ANK3 PAICS	1.30e-05	78	194	6	DOID:5419 (is_implicated_in)
Disease	asthma (is_marker_for)	IL13 CHI3L1 ADAM8 BMPR1B AGER NOS2 CD14	2.08e-05	126	194	7	DOID:2841 (is_marker_for)
Disease	Schizophrenia	CHL1 IL12B RELN CNNM2 RTN4R CHI3L1 CSMD2 NDUFV2 SLC12A5 JAG2 AGER ANK3 ADAMTS3 NTRK2 PSD3 SIRT1 RHD ATM	2.36e-05	883	194	18	C0036341
Disease	Glioma	IL12B CHI3L1 CLCN3 NTRK2 PSD3 ATM	2.43e-05	87	194	6	C0017638
Disease	Anemia, Hemolytic, Congenital	RHCE RHD	4.30e-05	2	194	2	C0002881
Disease	hearing loss	EYA4 ZNF318 COL9A3 DVL2 NOX4	8.10e-05	67	194	5	EFO_0004238
Disease	metabolite measurement	ABCC3 SLC12A5 PCBP4 ANK3 SLC16A9 TMPRSS11E PSD3 ACAD8 IGF2R MICAL2 MAP4K5 GADL1 CABIN1	9.32e-05	560	194	13	EFO_0004725
Disease	sulfate measurement	IL12B TMEM174 HTT	9.66e-05	14	194	3	EFO_0007864
Disease	Malignant Glioma	IL12B CHI3L1 CLCN3 NTRK2 PSD3	9.99e-05	70	194	5	C0555198
Disease	mixed gliomas	IL12B CHI3L1 CLCN3 NTRK2 PSD3	9.99e-05	70	194	5	C0259783
Disease	Manic Disorder	RELN SRPK2 NDUFV2 ANK3 NTRK2	1.07e-04	71	194	5	C0024713
Disease	Rh Deficiency Syndrome	RHCE RHD	1.28e-04	3	194	2	C0272052
Disease	level of killer cell immunoglobulin-like receptor 2DS2 in blood serum	KIR2DL1 KIR2DL3	1.28e-04	3	194	2	OBA_2042107
Disease	Rh-Null, Regulator Type	RHCE RHD	1.28e-04	3	194	2	C1849387
Disease	X-11261 measurement	SLC16A9 IGF2R	1.28e-04	3	194	2	EFO_0021221
Disease	Mood Disorders	RELN SLC12A5 ANK3 NTRK2 SIRT1 SIRT2 HTT	1.29e-04	168	194	7	C0525045
Disease	cutaneous psoriasis measurement, psoriasis	IL12B IL13 NOS2	1.47e-04	16	194	3	EFO_0000676, EFO_0007773
Disease	Disproportionate short stature	IFT140 BMPR1B WDR35 FLNB COL9A3	1.57e-04	77	194	5	C0878659
Disease	Manic	RELN SRPK2 NDUFV2 ANK3 NTRK2	1.67e-04	78	194	5	C0338831
Disease	monocyte count	RASGRP4 NLRP12 TNFSF14 BCAS3 HLX ACVRL1 CIITA ZMIZ2 POC1B PKD1 SELL FLNB STXBP5 SMTNL1 CD14 MAP4K5 ATM SPIDR UBASH3B CABIN1 ACKR1	1.74e-04	1320	194	21	EFO_0005091
Disease	Depression, Bipolar	RELN SRPK2 NDUFV2 ANK3 NTRK2	1.77e-04	79	194	5	C0005587
Disease	osteochondrodysplasia (is_implicated_in)	BMPR1B FLNB COL9A3	2.51e-04	19	194	3	DOID:2256 (is_implicated_in)
Disease	Takayasu Arteritis	IL12B NOS2	2.56e-04	4	194	2	C0039263
Disease	Lewy Body Disease	AGER NTRK2 IGF2R	3.93e-04	22	194	3	C0752347
Disease	systemic scleroderma (is_marker_for)	IL13 CHI3L1 AGER ADAMTS13	4.12e-04	53	194	4	DOID:418 (is_marker_for)
Disease	granulocyte percentage of myeloid white cells	NLRP12 TNFSF14 HLX POC1B FLNB LRRC25 MAP4K5 UBASH3B	4.20e-04	268	194	8	EFO_0007997
Disease	Premature Menopause	BMPR1B FOXO4	4.24e-04	5	194	2	C0025322
Disease	paraplegia (biomarker_via_orthology)	FOXO4 NOS2	4.24e-04	5	194	2	DOID:607 (biomarker_via_orthology)
Disease	neural cell adhesion molecule l1-like protein measurement	CHL1 DCBLD2	4.24e-04	5	194	2	EFO_0020595
Disease	glutamate receptor ionotropic, delta-2 measurement	IGHV3-23 SIGLEC1	4.24e-04	5	194	2	EFO_0801631
Disease	Plasmodium falciparum malaria (is_marker_for)	IL13 ADAMTS13	4.24e-04	5	194	2	DOID:14067 (is_marker_for)
Disease	Metastatic melanoma	BMPR1B MAP3K10 MAP4K1 PKN1	4.43e-04	54	194	4	C0278883
Disease	triglycerides in LDL measurement	GALNT2 PSD3 IGF2R MAP4K5	5.09e-04	56	194	4	EFO_0022320
Disease	mental development measurement	PCDHGB3 PCDHGA2 WWTR1	5.78e-04	25	194	3	EFO_0008230
Disease	triglycerides in IDL measurement	GALNT2 PSD3 IGF2R MAP4K5	5.82e-04	58	194	4	EFO_0022149
Disease	Atherosclerosis	AGER NOS2 SIRT1 TRIM28	6.22e-04	59	194	4	C0004153
Disease	Atherogenesis	AGER NOS2 SIRT1 TRIM28	6.22e-04	59	194	4	C1563937
Disease	rgm domain family member b measurement	RGMB MAP4K5	6.34e-04	6	194	2	EFO_0020708
Disease	Alcohol Related Birth Defect	ANK3 NTRK2	6.34e-04	6	194	2	C3146244
Disease	galectin-3-binding protein measurement	TIMP2 SIGLEC1	6.34e-04	6	194	2	EFO_0010241
Disease	cystic fibrosis (is_marker_for)	IL13 AGER NOS2 CD14	7.50e-04	62	194	4	DOID:1485 (is_marker_for)
Disease	triglycerides in medium LDL measurement	GALNT2 PSD3 IGF2R MAP4K5	7.50e-04	62	194	4	EFO_0022322
Disease	urolithiasis	BCAS3 SHROOM3 MAP4K5 PKN1	7.97e-04	63	194	4	MONDO_0024647
Disease	pulmonary hypertension (is_marker_for)	IL13 BMPR1B AGER NOS2	8.46e-04	64	194	4	DOID:6432 (is_marker_for)
Disease	triglyceride measurement, intermediate density lipoprotein measurement	GALNT2 SHROOM3 PSD3 IGF2R MAP4K5	8.51e-04	111	194	5	EFO_0004530, EFO_0008595
Disease	blood urea nitrogen measurement	GGNBP2 BCAS3 ZNF318 ACVRL1 TMEM174 PKHD1 SHROOM3 SIRT1 MAP4K5 UBASH3B	8.69e-04	452	194	10	EFO_0004741
Disease	neuropilin-1 measurement	GALNT2 MAP4K5	8.84e-04	7	194	2	EFO_0020603
Disease	nucleoside diphosphate kinase B measurement	NLRP12 SPAG9	8.84e-04	7	194	2	EFO_0020615
Disease	Grand Mal Status Epilepticus	SLC12A5 NOS2 ANK3 NTRK2	1.00e-03	67	194	4	C0311335
Disease	Petit mal status	SLC12A5 NOS2 ANK3 NTRK2	1.00e-03	67	194	4	C0270823
Disease	Complex Partial Status Epilepticus	SLC12A5 NOS2 ANK3 NTRK2	1.00e-03	67	194	4	C0393734
Disease	Status Epilepticus, Subclinical	SLC12A5 NOS2 ANK3 NTRK2	1.00e-03	67	194	4	C0751522
Disease	Simple Partial Status Epilepticus	SLC12A5 NOS2 ANK3 NTRK2	1.00e-03	67	194	4	C0751524
Disease	Non-Convulsive Status Epilepticus	SLC12A5 NOS2 ANK3 NTRK2	1.00e-03	67	194	4	C0751523
Disease	triglycerides in very small VLDL measurement	GALNT2 PSD3 IGF2R MAP4K5	1.06e-03	68	194	4	EFO_0022144
Disease	Status Epilepticus	SLC12A5 NOS2 ANK3 NTRK2	1.06e-03	68	194	4	C0038220
Disease	morbid obesity (is_implicated_in)	AGER NTRK2	1.17e-03	8	194	2	DOID:11981 (is_implicated_in)
Disease	isobutyrylcarnitine measurement	SLC16A9 ACAD8	1.17e-03	8	194	2	EFO_0021023
Disease	sialic acid-binding Ig-like lectin 12 measurement	NLRP12 MAP4K5	1.17e-03	8	194	2	EFO_0802066
Disease	pulmonary fibrosis (is_marker_for)	IL13 CHI3L1 AGER	1.21e-03	32	194	3	DOID:3770 (is_marker_for)
Disease	type 1 diabetes mellitus (is_marker_for)	CHI3L1 AGER CD14 TIMP2	1.31e-03	72	194	4	DOID:9744 (is_marker_for)
Disease	Alzheimer disease	RELN BCAS3 ATXN7L1 ABCA7 PKHD1 WWC1 ANK3 DVL2 TRIM56 CLEC3B	1.47e-03	485	194	10	MONDO_0004975
Disease	tumor necrosis factor ligand superfamily member 14 measurement	NLRP12 TNFSF14	1.50e-03	9	194	2	EFO_0010613
Disease	advanced glycation end-product measurement	AGER PSD3	1.50e-03	9	194	2	EFO_0007819
Disease	X-11381 measurement	SLC16A9 IGF2R	1.50e-03	9	194	2	EFO_0021228
Disease	immunoglobulin M measurement	SIGLEC1 CMTM7	1.50e-03	9	194	2	EFO_0020466
Disease	psoriasis, type 2 diabetes mellitus	IL12B IL13 NOS2 CWF19L1	1.53e-03	75	194	4	EFO_0000676, MONDO_0005148
Disease	serum metabolite measurement	GALNT2 SRPK2 ABCA7 FOXK1 IGHV3-48 SLC16A9 NTRK2 TMPRSS11E PSD3 ACAD8 IGF2R MAP4K5 TRIM56 GADL1 ELP2	1.54e-03	945	194	15	EFO_0005653
Disease	creatinine measurement, chronic kidney disease	BCAS3 SHROOM3 MAP4K5	1.57e-03	35	194	3	EFO_0003884, EFO_0004518
Disease	endometrial cancer (is_marker_for)	CHI3L1 HTRA2 SPAG9	1.57e-03	35	194	3	DOID:1380 (is_marker_for)
Disease	asthma (implicated_via_orthology)	IL13 AGER NOS2	1.57e-03	35	194	3	DOID:2841 (implicated_via_orthology)
Disease	Parkinson's disease (is_implicated_in)	NDUFV2 HTRA2 ATM HTT	1.61e-03	76	194	4	DOID:14330 (is_implicated_in)
Disease	carnitine measurement	ZNF318 ANK3 SLC16A9 ACAD8	1.61e-03	76	194	4	EFO_0010469
Disease	Alzheimer's disease (is_marker_for)	RELN AGER NOS2 SELL HTRA2 TIMP2 ATM	1.62e-03	257	194	7	DOID:10652 (is_marker_for)
Disease	Tinnitus	ZNF318 JAG2 PKHD1 KRT78 SPATA31A1	1.72e-03	130	194	5	HP_0000360
Disease	monounsaturated fatty acids; 16:1, 18:1 measurement	GALNT2 PSD3 IGF2R MAP4K5	1.77e-03	78	194	4	EFO_0022187
Disease	amino acid measurement	GALNT2 RTN4R HLX C16orf89 PSD3 WWTR1 ACAD8 MAP4K5 SLIT1 PKN1 HTT TRMT61A	1.86e-03	678	194	12	EFO_0005134
Disease	urea measurement	BCAS3 SHROOM3	1.87e-03	10	194	2	EFO_0011005
Disease	head circumference	NIBAN1 TIMP2	1.87e-03	10	194	2	EFO_0005114
Disease	uremia (biomarker_via_orthology)	AGER NOS2	1.87e-03	10	194	2	DOID:4676 (biomarker_via_orthology)
Disease	serum urea measurement	CHAF1B ZNF318 TMEM174 SHROOM3 DVL2 MAP4K5	1.89e-03	195	194	6	EFO_0009795
Disease	gout	BCAS3 TMEM174 SLC16A9 NTRK2 PSD3 MAP4K5	1.94e-03	196	194	6	EFO_0004274
Disease	omega-6 polyunsaturated fatty acid measurement	TMPRSS11E PSD3 RHD IGF2R MAP4K5 TMEM39A	1.99e-03	197	194	6	EFO_0005680
Disease	neutrophil count	EYA4 HLX SRPK2 ACVRL1 ABCA7 JAG2 PKD1 FLNB STXBP5 PSD3 SIRT1 LRRC25 MICAL2 MAP4K5 UBASH3B ACKR1 HYDIN HTT TRMT61A	2.00e-03	1382	194	19	EFO_0004833
Disease	Liver carcinoma	CHAF1B MBTPS1 PPP4R3C KIF11 PAMR1 ADAMTS13 ZNF23 IGF2R CELSR3 ATM	2.04e-03	507	194	10	C2239176
Disease	SCHIZOPHRENIA	RTN4R CHI3L1	2.27e-03	11	194	2	181500
Disease	uric acid measurement	CNNM2 BCAS3 ZNF318 TMEM174 FOXK1 SHROOM3 NPTX1 SLC16A9 ANKRD50 MAP4K5 UBASH3B	2.48e-03	610	194	11	EFO_0004761
Disease	collagen disease (implicated_via_orthology)	COL4A3 COL4A6	2.72e-03	12	194	2	DOID:854 (implicated_via_orthology)
Disease	level of Diacylglycerol (18:1_18:2) in blood serum	GALNT2 MAP4K5	2.72e-03	12	194	2	OBA_2045171
Disease	non-high density lipoprotein cholesterol measurement	GGNBP2 GALNT2 PRSS53 POC1B ADAMTS3 PSD3 IGF2R MAP4K5 UBASH3B CMTM7 CWF19L1 HYDIN	2.81e-03	713	194	12	EFO_0005689
Disease	triglycerides in large LDL measurement	GALNT2 IGF2R MAP4K5	2.85e-03	43	194	3	EFO_0022319
Disease	schizophrenia (is_marker_for)	RELN ANK3 NTRK2	3.04e-03	44	194	3	DOID:5419 (is_marker_for)
Disease	free cholesterol measurement, very low density lipoprotein cholesterol measurement	GALNT2 TMPRSS11E PSD3 RHCE IGF2R MAP4K5	3.08e-03	215	194	6	EFO_0008317, EFO_0008591
Disease	Depressive disorder	RELN CSMD2 NOS2 WWC1 NTRK2 TG HTT	3.13e-03	289	194	7	C0011581
Disease	plasma beta-amyloid 1-42 measurement	ACSS3 ANK3	3.20e-03	13	194	2	EFO_0005660
Disease	Short Rib-Polydactyly Syndrome	IFT140 WDR35	3.20e-03	13	194	2	C0036996
Disease	intracranial aneurysm (biomarker_via_orthology)	AGER TIMP2	3.20e-03	13	194	2	DOID:10941 (biomarker_via_orthology)
Disease	Connective Tissue Diseases	PKD1 COL9A3	3.20e-03	13	194	2	C0009782
Disease	Fetal Alcohol Spectrum Disorders	CHL1 ANK3	3.20e-03	13	194	2	C2985290
Disease	bronchiolitis obliterans (is_marker_for)	IL13 NOS2	3.20e-03	13	194	2	DOID:2799 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
LVGSRGLGCSISSGP	USH1C	216	Q9Y6N9
IGELGNISLSCPVSG	BMP3	136	P12645
AEGGGQSLVSPGSCL	COL4A6	1611	Q14031
LLGTGTDSSEPCGLS	C16orf89	166	Q6UX73
GAIGAQGTPGICDTS	COL9A3	651	Q14050
QCLTGTNGISSGLAP	ANKRD10	301	Q9NXR5
GCSSETGLLPGSIFA	CWC25	106	Q9NXE8
EGTSTLSCILGPDGK	CSMD2	1591	Q7Z408
SEGTGQALASPGSCL	COL4A3	1591	Q01955
SCIVVEKGTPGLSFG	ACAD8	216	Q9UKU7
GDRLGVQLCGTASSP	BEGAIN	521	Q9BUH8
ILSLDSTQACGAGGP	C2orf48	136	Q96LS8
EGVPESLVALSTCSG	ADAM20	116	O43506
LDLRSTGICPSGLGS	CIITA	861	P33076
TGICPSGLGSLVGLS	CIITA	866	P33076
SDVEVGCSALRSPGG	EVX2	116	Q03828
GSLLLTPAGCVESGE	CHAF1B	246	Q13112
TLPVTLASGASGGLC	ACKR1	181	Q16570
DCTTGSGSGLPFLVQ	ACVRL1	181	P37023
VGGPGSGKTALCTEL	ANKRD50	76	Q9ULJ7
TSSLGSGGPDCAITV	CELSR1	2966	Q9NYQ6
TCGVSDDSLGSLLGP	ADAM8	166	P78325
RPSVTCDQGSSTIGG	C5orf52	6	A6NGY3
RPLLGVCKSIGSSGT	BCAS3	146	Q9H6U6
DSGLPVVTSGCLGLE	BMPR1B	61	O00238
SCGIVPLASPGTSAE	C2orf73	126	Q8N5S3
TITSGSSLPDGCEGR	DVL2	401	O14641
RQVGAVGGSSDSCPL	ATXN7L1	731	Q9ULK2
SGPREDGTLSLCVSG	ADAMTS13	511	Q76LX8
SEALCSVRGPSSTVG	ABCA7	221	Q8IZY2
SSGTNGVSLPADCTG	RANBP3	191	Q9H6Z4
VGTCVSEGSYPAGTL	AGER	141	Q15109
GGAVAPGGTVTLTCE	AGER	246	Q15109
ISCPSSEGAVGTTEA	PDZRN3	786	Q9UPQ7
DGGDPVLSGTSRICV	PCDHGA2	216	Q9Y5H1
NTVTVSPDGSLCASG	RACK1	196	P63244
GPTVLAGESVTLSCS	KIR2DS2	136	P43631
GPVGCGKSSLVSALL	ABCC3	661	O15438
GCSAEGVTGAATSPS	SPAG9	846	O60271
TGTGIVCGSGARPDL	LRRC3C	181	A6NJW4
LGRCESQSTLDPGAG	NPTX1	86	Q15818
LLVVTSTFGNGDCPG	NOS2	586	P35228
SLASGVGLLASPVCS	SLC16A9	56	Q7RTY1
GASVELRCGVSTPGS	NPHS1	46	O60500
GSCPERITTITGSTA	PCBP4	56	P57723
PSDSGTRVLIGCVTS	CT55	106	Q8WUE5
VQPGGSLRLSCAASG	IGHV3-72	31	A0A0B4J1Y9
GPTVLAGESVTLSCS	KIR2DL2	136	P43627
GGIISCGTTHTALVP	SLC25A3	71	Q00325
IRLTPVDCGGSSSGS	MAP3K10	516	Q02779
VQPGGSLRLSCAASG	IGHV3-43D	31	P0DP04
SVGSVLGACLGNSPS	IFI27L2	81	Q9H2X8
GPSAGVTIVTCLASL	LONP2	741	Q86WA8
GALTGGTEVSALPCT	MAP7	631	Q14244
CASSLGGGGASELLP	HLX	451	Q14774
CGKPITEESSTLGEG	CHL1	1001	O00533
GCRALSGTSVASPVV	MBTPS1	406	Q14703
GAPGQRVTISCTGSS	IGLV1-50	31	A0A075B6I6
QGVGPGCTDETLLSA	MBD3	166	O95983
LGSCITDPGNRETSG	GGNBP2	551	Q9H3C7
VSIQAPGSSECSGSL	GPR179	1441	Q6PRD1
GPTVLAGESVTLSCS	KIR2DL3	136	P43628
LEGATGFRPSGCITT	WWC1	486	Q8IX03
VQPGGSLRLSCAASG	IGHV3-7	31	P01780
VKPSGTLSLTCAVSG	IGHV4-4	31	A0A075B6R2
GGSSTGLLVPVLCGA	JAG2	1076	Q9Y219
SVDAGVDCSSIGGVP	KIF11	996	P52732
SCAPGLASATIGAVV	LRRC25	156	Q8N386
VQPGGSLRLSCAASG	IGHV3-38-3	31	P0DTE1
KSGGLSVEVCGPALS	GALNT2	546	Q10471
DSASEGSEGLGPCVL	MCM3AP	576	O60318
GSEGLGPCVLSLSTL	MCM3AP	581	O60318
VQPGGSLRLSCAASG	IGHV3-13	31	P01766
AGTLSPEADCLGTGA	LNX2	171	Q8N448
SRTALSVGGAPCTVL	B4GALT7	296	Q9UBV7
CGSALVSSLATGLKP	CWF19L1	176	Q69YN2
TLASSETGVGAPISG	CHI3L1	266	P36222
VQPGGSLRLSCAASG	IGHV3-48	31	P01763
TLPAGSGSNDETCTG	GSPT2	81	Q8IYD1
TGDASKCLATGPGIA	FLNB	1611	O75369
GLPSSSKLATGVGLC	FOXO4	401	P98177
SAEVTGLPGVSAGLT	MUC19	5176	Q7Z5P9
GCPALEGSVGLSNSV	RASGRP4	236	Q8TDF6
VPGTTAGKLTASACI	KCNS2	381	Q9ULS6
TVIALTCLGGFASPG	IL13	21	P35225
GSGKDPVLDSCSVSG	KRT78	481	Q8N1N4
QGSGPEFGLVTTCGT	LMLN2	436	A0A1B0GTW7
TNLTGIEETTCGPFG	SELL	231	P14151
GPTVLAGESVTLSCS	KIR2DS3	136	Q14952
VLAVDPSSCTSGGSL	MMAA	176	Q8IVH4
VQPGGSLRLSCAASG	IGHV3-74	31	A0A0B4J1X5
PSGTCIASAGSDQTV	POC1B	196	Q8TC44
VLTAVDGGEPSRSCT	PCDHGB3	211	Q9Y5G1
QGISLTGSVACGRPS	PRSS38	41	A1L453
GSSDPQGVTCGAATL	IL12B	161	P29460
VPSKFSGISGCSDGV	RICTOR	1566	Q6R327
VQPGGSLRLSCAASG	IGHV3-43	31	A0A0B4J1X8
SLCVAGGIGVTPFAS	NOX4	426	Q9NPH5
AVIGTECGTIESGLS	RELN	436	P78509
GPTVLAGESVTLSCS	KIR2DS5	136	Q14953
TESSVIPCGGTVAAA	NUTM1	781	Q86Y26
CAAIGTGSPSGSSVV	PPP4R3C	781	Q6ZMV5
VSPGGTVTLTCGLSS	IGLV8-61	36	A0A075B6I0
GVAVLGACPSASEGV	MYO15B	61	Q96JP2
SISVSDAPGSGIIDC	ERVK-9	101	P63126
VGSCLGEVGPIDFST	ATM	1671	Q13315
PGTSVAISNCDGLAG	ADAMTS3	156	O15072
SGVVPACARSTLSVG	CD14	346	P08571
SSANLCLPTGVRGGV	EYA4	461	O95677
LSVGVTEPRACLTSG	HTRA2	61	O43464
VELIAGGGSSCSPVL	HTT	421	P42858
IQGGSPLSLTLSGVC	HYDIN	4611	Q4G0P3
AALGTGAEPTCSQEG	CABIN1	2056	Q9Y6J0
DLCVSAPTGSGKTLA	DDX51	251	Q8N8A6
LATTGCPGVSTQGLT	FCGBP	4101	Q9Y6R7
FLPEGDICVVGSTSG	PIK3CD-AS1	56	Q5SR53
SGGLQTPECLSREGS	FOXK1	431	P85037
GVPISGCLGDQSAAL	GK	256	P32189
IPTSGECQEGTSSSG	ANK3	3686	Q12955
VQPGGSLRLSCAASG	IGHV3-23	31	P01764
SGECGSSFPQVVGSL	HAUS6	101	Q7Z4H7
FVSSGCQPLGGISSV	KRTAP11-1	106	Q8IUC1
LGAAPSQRCGLTGSE	FTCDNL1	121	E5RQL4
CPGDSSSVGKVSVLG	ELP5	151	Q8TE02
GCGHTVLGPESGTLT	DCBLD2	71	Q96PD2
SGPRGLLAFGTSCSV	ELP2	26	Q6IA86
GPCSSVLDVGGAVTA	ELP2	711	Q6IA86
PFLVCATSGTTVLGA	GADL1	266	Q6ZQY3
IGGGALALCPESSGV	CELSR3	56	Q9NYQ7
VQPGGSLRLSCAASG	IGHV3-16	31	A0A0C4DH30
VPGVGGIASLRCSSS	IFT140	566	Q96RY7
GPTVLAGENVTLSCS	KIR2DL1	136	P43626
SCGPVAETSSIGNGD	MAP4K5	436	Q9Y4K4
RVSGIGKPVLCSSSG	MICAL2	741	O94851
SSCAVAAIGTLEGSP	MICAL2	1096	O94851
GDGSSNTTVRGCPTV	PKD1	1331	P98161
CTAETGGIAAVSFPG	PAMR1	661	Q6UXH9
GTSTPCDSFGIGVSV	PCARE	451	A6NGG8
FSTCGAGLQSLTGAP	SLC12A5	516	Q9H2X9
VQPGGSLRLSCAASG	IGHV3-35	31	A0A0C4DH35
GPTVLAGENVTLSCS	KIR2DS1	136	Q14954
ASSGGPFLCGALETS	MAP4K1	616	Q92918
LVTEQDGCSPSGAGA	NUTM2E	186	B1AL46
GCPLLTTTGLSGLVQ	FBXL16	431	Q8N461
LGCDLGASGLTPASG	FOXN4	456	Q96NZ1
LESAPVLRTSGEGGC	IGF2R	591	P11717
TGDSEGSGALPSLTC	RTN4R	441	Q9BZR6
PSGSQLLVGCEDGSV	UTP4	111	Q969X6
PRGGSDLSVSLGLTC	RGMB	416	Q6NW40
TLGAAGQPLGGESIC	SPON2	21	Q9BUD6
GAPGQRVTISCTGSS	IGLV1-40	31	P01703
SLESLVGCVLSGPTS	RIF1	606	Q5UIP0
CLTETGSGAGDLAAP	FOXN1	586	O15353
GPSSATCESGAGSEV	SPATA31A7	841	Q8IWB4
GSGCKAIGDSSVPSE	SHROOM3	1301	Q8TF72
GAGVSVSCGIPDFRS	SIRT1	261	Q96EB6
CLVGAGISTSAGIPD	SIRT2	81	Q8IXJ6
PSQGSACGGTILTVR	PKHD1	1396	P08F94
GGPTCSATNLSRVAG	PKN1	116	Q16512
PSGAGLCDISEGTVV	STXBP5	691	Q5T5C0
DSTISPCLFVGTSLG	STXBP5L	846	Q9Y2K9
SISVSDAPGSGIIDC	ERVK-9	101	P63128
CEAALGSGLVPGGSA	SSH3	211	Q8TE77
CGVGTLLSTPAAATS	AMMECR1	91	Q9Y4X0
TETGSPITASCVGLG	ACSS3	451	Q9H6R3
GLVRTTCSSGSALGP	CMTM7	6	Q96FZ5
ACGSGIPEIKTILSG	CLCN3	236	P51790
LCTSLSTPALGAGGS	CNNM2	191	Q9H8M5
GKSITLSCSVAGDPV	NTRK2	211	Q16620
GLGCSTVLSPEGSAQ	PAICS	371	P22234
GPSSATCESGAGSEV	SPATA31A3	841	Q5VYP0
TDACQGDSGGPLVSS	TMPRSS11E	366	Q9UL52
SAVGELPSCEGLSGA	PRSS53	466	Q2L4Q9
SPGCTTLLSTGSLEA	USP19	886	O94966
LPSGIHSALGTVSCG	TULP2	86	O00295
SLDQGCVGGSFPSTV	TMTC1	186	Q8IUR5
AGGVAVGTSCHLIPS	RHD	276	Q02161
AGGVAVGTSCHLIPS	RHCE	276	P18577
LPGTCSSELEFGGTL	NIBAN1	676	Q9BZQ8
GALSFGVTTCDPGTL	NEURL1	351	O76050
GPSSATCESGAGSEV	SPATA31A1	841	Q5TZJ5
GQATCAASLTVRPGG	SPEG	801	Q15772
RCTGGEVGATSALAP	RPL12	16	P30050
LSTDGLGPDCVASGQ	SMTNL1	286	A8MU46
GPSSATCESGAGSEV	SPATA31A5	841	Q5VU36
GVGCPLGLASTITHG	TNFSF14	151	O43557
LLSVVSGASSCELPG	SPIDR	746	Q14159
EDCISRGGTLGTPQT	CLEC3B	96	P05452
SALPSLQTLVGGGCG	TMEM39A	16	Q9NV64
SLEPVACGSVLSEGS	SRPK2	461	P78362
LRPGSVVCESGTGSG	TRMT61A	101	Q96FX7
TAPSSAVCGVSLDVG	TIMP2	91	P16035
SSPNACGGIALILSG	TPP2	451	P29144
GQGGTLCLVGVSTPS	nan	36	Q6ZSV7
EPAGTSRDAGVVCSG	SCART1	521	Q4G0T1
TAIPGAFGCGKTVIS	ATP6V1A	246	P38606
LGLVGPGGATVSSIC	TMEM8B	456	A6NDV4
RVVATSLPSGGGCST	SIGLEC1	641	Q9BZZ2
SAVTVSVGPVGCSLL	PKHD1L1	1096	Q86WI1
SGPGGVVACLEISAA	WDR6	456	Q9NNW5
VAGGSSALTSPQCLG	ZMIZ2	76	Q8NF64
VSPCGLITSGGAAAA	TMEM174	161	Q8WUU8
VFVGAPTGSGKTICA	SNRNP200	1346	O75643
VSSGCPATSVSEGIG	ZNF445	336	P59923
PVTESLLCTGSTDGV	WDR55	261	Q9H6Y2
QGSGTTTGCGLPSIE	TARBP2	6	Q15633
IYGTSLTTGCSGLLP	UBASH3B	296	Q8TF42
GEQPSGCTGLGKSIS	ZNF23	136	P17027
EGGEGKLPTCVATGS	WDR35	1131	Q9P2L0
QGEAGRVPTCTLSSG	SLIT1	266	O75093
GGTILCETISGPTGS	TG	1226	P01266
PLTGCHSGLDSVTEG	PSD3	96	Q9NYI0
GTGCSIPGLSGVLTA	ZNF318	346	Q5VUA4
GGPGTLDDSATICRV	TRIM28	616	Q13263
LVGGTSTGGPATARC	TRIM56	106	Q9BRZ2
STDSGLGLGCYSVPT	WWTR1	311	Q9GZV5
GGPSSLGNQSTCLLE	NLRP12	101	P59046
GRFSCEPAGGLTSLT	NDUFV2	221	P19404